The Angiotensin II Type 2 Receptor for Pain Control

Jan Danser; P Anand

doi:10.1016/j.cell.2014.05.030

The Angiotensin II Type 2 Receptor for Pain Control

Jan Danser, P Anand

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

28 Citations (Scopus)

Abstract

All well-known deleterious effects of angiotensin (Ang) II, including vasoconstriction, inflammation, water and salt retention, and vascular remodeling, are mediated via its type 1 (AT(1)) receptor. This explains why AT(1) receptor blockers (ARBs) and inhibitors of Ang II synthesis, such as ACE inhibitors and renin inhibitors, are beneficial for cardiovascular disease. Yet, Ang II has a second receptor, the Ang II type 2 (AT(2)) receptor, the function of which, even after over 20 years of research, remains largely unknown. In this issue, Marion et al. provide a new chapter to the AT(2) receptor story.

Original language	Undefined/Unknown
Pages (from-to)	1504-1506
Number of pages	3
Journal	Cell
Volume	157
Issue number	7
DOIs	https://doi.org/10.1016/j.cell.2014.05.030
Publication status	Published - 2014

Research programs

EMC COEUR-09

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cell.2014.05.030

http://hdl.handle.net/1765/81473

Cite this

@article{517cfe47aca9484ba82b783d97caa359,

title = "The Angiotensin II Type 2 Receptor for Pain Control",

abstract = "All well-known deleterious effects of angiotensin (Ang) II, including vasoconstriction, inflammation, water and salt retention, and vascular remodeling, are mediated via its type 1 (AT(1)) receptor. This explains why AT(1) receptor blockers (ARBs) and inhibitors of Ang II synthesis, such as ACE inhibitors and renin inhibitors, are beneficial for cardiovascular disease. Yet, Ang II has a second receptor, the Ang II type 2 (AT(2)) receptor, the function of which, even after over 20 years of research, remains largely unknown. In this issue, Marion et al. provide a new chapter to the AT(2) receptor story.",

author = "Jan Danser and P Anand",

year = "2014",

doi = "10.1016/j.cell.2014.05.030",

language = "Undefined/Unknown",

volume = "157",

pages = "1504--1506",

journal = "Cell",

issn = "0092-8674",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - The Angiotensin II Type 2 Receptor for Pain Control

AU - Danser, Jan

AU - Anand, P

PY - 2014

Y1 - 2014

N2 - All well-known deleterious effects of angiotensin (Ang) II, including vasoconstriction, inflammation, water and salt retention, and vascular remodeling, are mediated via its type 1 (AT(1)) receptor. This explains why AT(1) receptor blockers (ARBs) and inhibitors of Ang II synthesis, such as ACE inhibitors and renin inhibitors, are beneficial for cardiovascular disease. Yet, Ang II has a second receptor, the Ang II type 2 (AT(2)) receptor, the function of which, even after over 20 years of research, remains largely unknown. In this issue, Marion et al. provide a new chapter to the AT(2) receptor story.

AB - All well-known deleterious effects of angiotensin (Ang) II, including vasoconstriction, inflammation, water and salt retention, and vascular remodeling, are mediated via its type 1 (AT(1)) receptor. This explains why AT(1) receptor blockers (ARBs) and inhibitors of Ang II synthesis, such as ACE inhibitors and renin inhibitors, are beneficial for cardiovascular disease. Yet, Ang II has a second receptor, the Ang II type 2 (AT(2)) receptor, the function of which, even after over 20 years of research, remains largely unknown. In this issue, Marion et al. provide a new chapter to the AT(2) receptor story.

U2 - 10.1016/j.cell.2014.05.030

DO - 10.1016/j.cell.2014.05.030

M3 - Article

C2 - 24949962

SN - 0092-8674

VL - 157

SP - 1504

EP - 1506

JO - Cell

JF - Cell

IS - 7

ER -